NSABP MEMBER--MT SINAI MEDICAL CENTER

描述（改编自申请人摘要）：本研究计划 是为了让Mt继续参与。Sinai Medical 中心（MSMC）的NSABP试验。 该工作人员致力于实现 NSABP的目标是提高无病生存率 原发性可手术乳腺癌和结直肠癌患者的 癌的 理查德·伯恩斯坦博士曾担任乳房委员会主席，现在是 她是乳腺联合委员会的成员，沿着的还有她们的护士谢丽尔 雷诺兹 伯恩斯坦和雷诺兹都是该集团的高管 以马克思 Reynolds担任临床研究助理委员会主席。 它 他们打算继续共同撰写科学论文， 所有符合条件的患者参加这些试验。 他们成功地在 迄今已累计471名患者，其中350名目前正在随访中。 定期 定期对他们的转诊医生的业绩网站进行审计， 的基础，并将继续下去。 他们预计，一旦新的 协议可用。 他们的社区外展计划 生产力，并不断增长。

DESCRIPTION (adapted from the applicant's abstract): This research proposal is designed to enable continued participation by the Mt. Sinai Medical Center (MSMC) on the NSABP trials. This staff is dedicated to achieving the aims of the NSABP which are specifically to improve disease-free survival and survival in patients with primary operable breast and colorectal cancers. Dr. Richard Bornstein has chaired the Breast Committee, and is now a member of the Combined Breast Committee along with their nurse, Sheryl Reynolds. Both Bornstein and Reynolds are on the group's executive committee. Reynolds chairs the Clinical Research Associate Committee. It is their intention to continue to co-author scientific papers and to accrue all eligible patients to these trials. They have been successful in accruing 471 patients thus far, with 350 currently in follow-up. Periodic auditing of their referring doctors' performance sites occur on a regular basis and will continue. They expect accrual to increase rapidly once new protocols are available. Their community outreach program remains productive and is growing.